Literature DB >> 33508254

Reappraisal of pathological features of intraductal papillary neoplasm of bile duct with respect to the type 1 and 2 subclassifications.

Yasuni Nakanuma1, Katsuhiko Uesaka2, Yukiyasu Okamura2, Takuro Terada3, Yuki Fukumura4, Yuko Kakuda5, Takashi Sugino5, Yasunori Sato6, Jang Kee Taek7, Young Nyun Park8.   

Abstract

The pathological spectrum of intraductal papillary neoplasm of bile duct (IPNB) remains to be clarified. A total of 186 IPNBs were pathologically examined using the type 1 and 2 subclassifications proposed by Japanese and Korean biliary pathologists incorporating a two-tiered grading system (low-grade and high-grade dysplasia), with reference to four subtypes (intestinal [i], gastric [g], pancreatobiliary [pb], and concocytic [o] subtype). IPNBs were classifiable into type 1 composed of low-grade dysplasia and 'high-grade dysplasia with regular structures' (69 IPNBs), and type 2 of 'high grade dysplasia with irregular structures and complicated lesions' (117 IPNBs). Type 1 was more common in the intrahepatic bile duct (78%), whereas type 2 was frequently located in the extrahepatic bile duct (58%). Mucin hypersecretion was more common in type 1 (61%) than in type 2 (37%). IPNBs were classifiable into the four subtypes: 86 iPNBs, 40 gIPNBs, 31 pbIPNBs, and 29 oIPNBs. The four subtypes were histologically evaluable with reference to the type 1 and 2 subclassifications. iIPNB and pbIPNBs were frequently classified as type 2, whereas types 1 and 2 were observed at similar rates in gIPNB and oIPNB. Stromal invasion was almost absent in type 1, irrespective of subtype, but was found in 66 of 117 type 2 IPNBs (P < .01), and postoperative outcome was favorable in IPNBs without invasion compared with IPNBs with invasion (P < .05). The type 1 and 2 subclassifications with reference to the four subtypes may provide useful information for understanding IPNB.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biliary tree; Intraductal papillary neoplasm of bile duct; Pancreas; Subclassification; Subtype

Year:  2021        PMID: 33508254     DOI: 10.1016/j.humpath.2021.01.002

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis.

Authors:  Stephanie Roessler; Benjamin Goeppert; Alphonse Charbel; Luca Tavernar; Thomas Albrecht; Fritz Brinkmann; Joanne Verheij; Eva Roos; Monika Nadja Vogel; Bruno Köhler; Christoph Springfeld; Alexander Brobeil; Peter Schirmacher; Stephan Singer; Arianeb Mehrabi
Journal:  Br J Cancer       Date:  2022-09-06       Impact factor: 9.075

Review 2.  Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.

Authors:  Taek Chung; Young Nyun Park
Journal:  Front Med (Lausanne)       Date:  2022-03-31

3.  Comparison of the Malignant Predictors in Intrahepatic and Extrahepatic Intraductal Papillary Neoplasm of the Bile Duct.

Authors:  Sung Yong Han; Dong Uk Kim; Hyeong Seok Nam; Dae Hwan Kang; Sung Ill Jang; Dong Ki Lee; Dong Woo Shin; Kwang Bum Cho; Min Jae Yang; Jae Chul Hwang; Jin Hong Kim; Hoonsub So; Sung Jo Bang; Min Je Sung; Chang-Il Kwon; Dong Wook Lee; Chang-Min Cho; Jae Hee Cho
Journal:  J Clin Med       Date:  2022-04-02       Impact factor: 4.241

Review 4.  Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review.

Authors:  Mukul Vij; Yogesh Puri; Ashwin Rammohan; Gowripriya G; Rajesh Rajalingam; Ilankumaran Kaliamoorthy; Mohamed Rela
Journal:  World J Gastrointest Oncol       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.